Role of Gut Microbiome in Cancer Therapy

Recruiting now

Conditions studied: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

In brief

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.

Key facts

Study ID

NCT05112614

Run by

Mayo Clinic

People needed

3000

Starts

2019-09-11

Expected to finish

2030-10-01

Last updated by the study team

2026-03-16

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-99
• Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition

You may not qualify if…

• Unable to provide informed consent
• Vulnerable adults

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
• Mayo Clinic in Arizona — Scottsdale, Arizona, United States
• Mayo Clinic in Florida — Jacksonville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.